SREBP1-mediated lipid metabolism reprogramming drives malignant progression and therapeutic resistance in HPSCC organoids and animal models
- 21 January 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (6) , 1475-1487
Abstract
Head and neck squamous cell carcinoma (HNSCC) presents significant therapeutic challenges owing to its elevated recurrence rate and resistance to chemotherapeutic interventions. Tumor organoid models serve as essential platforms for investigating tumor physiology and pathological functions in vivo for its similarities in recapitulating the spatial structure of HNSCC. We employed HPSCC organoids from typical cell line and patient tissues, which faithfully recapitulated the tumor architecture, combined with CRISPR/Cas9 screening and TCGA-HNSCC database analysis. We identified SREBP1, a master regulator of lipid metabolism, as a key molecule whose expression escalates during HNSCC progression and correlates with improved patient survival and chemotherapy response. Functional studies demonstrated that SREBP1 downregulation conferred resistance to cisplatin and reduced cell death in both organoid and xenograft models in human hypopharyngeal carcinoma (HPSCC). We also found that the downregulation of SREBP1 was associated with enhanced resistance to cisplatin and a reduction in cell death in HPSCC-organoid models ex vivo and xenograft mouse models in vivo. Our findings establish SREBP1-mediated lipid rewiring as a critical determinant of HNSCC pathogenesis and treatment outcomes. Consequently, our model offers a promising solution for the swift and accurate evaluation of chemotherapy efficacy and identifies SREBP1 as a potential therapeutic target in HPSCC.Keywords
Funding Information
- National Natural Science Foundation of China (82101209)
- National Natural Science Foundation of China (82101212)
- National Natural Science Foundation of China (82301296)
- National Natural Science Foundation of China (82301297)
- National Natural Science Foundation of China (82471165)
- Science and Technology Commission of Shanghai Municipality (23ZR1440200)
This publication has 42 references indexed in Scilit:
- Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck CancerAdvanced Science, 2023
- Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progressionBiochemical Pharmacology, 2022
- Nutritional status at diagnosis is prognostic for pharyngeal cancer patients: a retrospective studyEuropean Archives of Oto-Rhino-Laryngology, 2022
- Head and neck cancerThe Lancet, 2021
- Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironmentCell, 2021
- Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancerSignal Transduction and Targeted Therapy, 2021
- PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinomaSignal Transduction and Targeted Therapy, 2021
- Head and neck cancer: Current challenges and future perspectives2021
- Mechanisms and Implications of Metabolic Heterogeneity in CancerCell Metabolism, 2019
- An Adipose Tissue Atlas: An Image-Guided Identification of Human-like BAT and Beige Depots in RodentsCell Metabolism, 2018